GENPHARMASEC LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 INR | +1.51% |
|
+4.12% | -56.75% |
| 05-24 | Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 05-24 | Genpharmasec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Genpharmasec Ltd is an India-based company, which is engaged in the distribution of the lucrative medical and diagnostics device segment. It is engaged in providing technology-based medical and diagnostics devices. The Company operates through two segments: Distribution of Diagnostic Equipmentâs and Investment and trading in Securities. The Company holds rights for distribution of equipments, such as i-STAT Analyzers and its Cartridges manufactured by Abbott Point of Care, USA all over India. The Company also holds distribution rights of Sphingotec Biomarkers and Joinstar System through Rivaara Labs Private Limited.
Sector
Pharmaceuticals
Calendar
2024-08-07
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -56.75% | 13.18M | |
| +54.61% | 811B | |
| +44.25% | 640B | |
| -6.33% | 353B | |
| +20.62% | 333B | |
| +10.44% | 302B | |
| +18.45% | 246B | |
| +2.09% | 225B | |
| +13.03% | 218B | |
| +8.61% | 168B |
- Stock Market
- Equities
- ADIRASA Stock
- News Genpharmasec Limited
- Genpharmasec Forms Subsidiary for Molecular Testing Services
